Here are some of the stocks that may see significant price movement today: Godrej Properties, NCC, Larsen & Toubro, etc.
This partnership is rooted in an innovative spirit in the realm of product design and scalable solutions fuelled to enhance worldwide patient care.
In conjunction with the renaming, there has been also an amendment to the company's Memorandum of Association (MoA) and Articles of Association (AoA).
This approval would allow Glenmark Therapeutics Inc., USA to market the product in the US market and would further fortify its ophthalmic portfolio.
The partnership was formalized via a Memorandum of Understanding (MoU) inked on March 20, 2025.
BHEL was awarded the contract following an international competitive bidding process and is expected to complete the project in 54 months.
Top gainers in Sensex include Bajaj Finance, Larsen, NTPC, Kotak Mahindra.
On March 20, 2025, the company disclosed this in a regulatory filing, which was approved by its Finance Committee.
Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets
With year-to-date order inflows nearing ₹9,200 crore, the company continues to expand its project portfolio.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.